$SHWZ
Medicine Man Technologies, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155837023014456 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $46.75M $42.38M
YoY Change 8.23% -4.27%
Cost Of Revenue $25.31M $17.86M
YoY Change 46.92% -6.55%
Gross Profit $21.44M $24.52M
YoY Change -17.43% -2.53%
Gross Profit Margin 45.86% 57.86%
Selling, General & Admin $9.639M $8.839M
YoY Change 43.32% 32.6%
% of Gross Profit 44.96% 36.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.058M $1.127M
YoY Change 32.51% 209.38%
% of Gross Profit 4.93% 4.6%
Operating Expenses $12.51M $19.56M
YoY Change -15.73% 21.34%
Operating Profit $8.924M $4.957M
YoY Change -19.72% -45.14%
Interest Expense -$3.804M -$6.422M
YoY Change 2.48% -121.99%
% of Operating Profit -42.63% -129.55%
Other Income/Expense, Net -$3.804M -$6.422M
YoY Change 2.48% -121.99%
Pretax Income $5.119M -$1.465M
YoY Change -30.85% -103.83%
Income Tax $5.442M $5.143M
% Of Pretax Income 106.3%
Net Earnings -$322.5K -$6.608M
YoY Change -117.82% -119.53%
Net Earnings / Revenue -0.69% -15.59%
Basic Earnings Per Share -$0.02 -$0.15
Diluted Earnings Per Share -$0.03 -$0.15
COMMON SHARES
Basic Shares Outstanding 70.59M 55.56M
Diluted Shares Outstanding 87.20M 60.54M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.08M $20.33M
YoY Change -48.74% -39.97%
Cash & Equivalents $19.62M $19.87M
Short-Term Investments $456.1K $456.1K
Other Short-Term Assets $6.486M $6.203M
YoY Change 9.91% -32.63%
Inventory $32.77M $33.82M
Prepaid Expenses
Receivables $5.050M $6.180M
Other Receivables $0.00 $0.00
Total Short-Term Assets $64.38M $66.53M
YoY Change -10.07% -0.41%
LONG-TERM ASSETS
Property, Plant & Equipment $32.14M $31.13M
YoY Change 25.58% 48.54%
Goodwill $76.58M $75.97M
YoY Change -23.11% -29.64%
Intangibles $168.8M $168.9M
YoY Change 51.99%
Long-Term Investments $2.000M $2.000M
YoY Change 316.89%
Other Assets $1.299M $1.223M
YoY Change -10.89% -16.48%
Total Long-Term Assets $306.2M $302.4M
YoY Change 18.69% 20.32%
TOTAL ASSETS
Total Short-Term Assets $64.38M $66.53M
Total Long-Term Assets $306.2M $302.4M
Total Assets $370.6M $369.0M
YoY Change 12.44% 15.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.67M $12.11M
YoY Change 102.64% 275.59%
Accrued Expenses $9.431M $6.398M
YoY Change 1.06% -28.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.250M $6.583M
YoY Change 183.33%
Total Short-Term Liabilities $50.40M $49.77M
YoY Change 67.75% 74.28%
LONG-TERM LIABILITIES
Long-Term Debt $150.9M $148.9M
YoY Change 22.78% 22.94%
Other Long-Term Liabilities $23.53M $22.10M
YoY Change 32.44% 91.6%
Total Long-Term Liabilities $174.4M $171.1M
YoY Change 24.0% 29.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.40M $49.77M
Total Long-Term Liabilities $174.4M $171.1M
Total Liabilities $224.8M $220.9M
YoY Change 31.7% 37.06%
SHAREHOLDERS EQUITY
Retained Earnings -$51.43M -$51.10M
YoY Change 172.06% 146.74%
Common Stock $72.61K $71.73K
YoY Change 29.5% 28.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.033M $2.033M
YoY Change 2.13% 2.13%
Treasury Stock Shares
Shareholders Equity $145.8M $148.1M
YoY Change
Total Liabilities & Shareholders Equity $370.6M $369.0M
YoY Change 12.44% 15.97%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$322.5K -$6.608M
YoY Change -117.82% -119.53%
Depreciation, Depletion And Amortization $1.058M $1.127M
YoY Change 32.51% 209.38%
Cash From Operating Activities $6.949M $2.683M
YoY Change 73.53% -119.45%
INVESTING ACTIVITIES
Capital Expenditures $4.767M $1.791M
YoY Change -186.6% -140.7%
Acquisitions
YoY Change
Other Investing Activities $17.60K -$15.83M
YoY Change -99.47% 183.46%
Cash From Investing Activities -$4.739M -$17.63M
YoY Change 114.72% 76.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.455M -352.9K
YoY Change -180.08% -103.55%
NET CHANGE
Cash From Operating Activities 6.949M 2.683M
Cash From Investing Activities -4.739M -17.63M
Cash From Financing Activities -2.455M -352.9K
Net Change In Cash -244.6K -15.29M
YoY Change -105.03% 10.62%
FREE CASH FLOW
Cash From Operating Activities $6.949M $2.683M
Capital Expenditures $4.767M $1.791M
Free Cash Flow $2.182M $892.7K
YoY Change -77.05% -109.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001622879
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55450
dei Entity Registrant Name
EntityRegistrantName
MEDICINE MAN TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5289499
dei Entity Address Address Line1
EntityAddressAddressLine1
4880 Havana Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80239
dei City Area Code
CityAreaCode
(303)
dei Local Phone Number
LocalPhoneNumber
371-0387
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
70590451
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19872099
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38949253
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6179662
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4471978
CY2023Q2 us-gaap Inventory Net
InventoryNet
33821282
CY2022Q4 us-gaap Inventory Net
InventoryNet
22554182
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
11944
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1816
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
39270
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
456099
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
454283
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6203056
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5293393
CY2023Q2 us-gaap Assets Current
AssetsCurrent
66532198
CY2022Q4 us-gaap Assets Current
AssetsCurrent
71735033
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7007889
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4899977
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31128357
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27089026
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
2000000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
2000000
CY2023Q2 us-gaap Goodwill
Goodwill
75968130
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24981817
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16290862
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168892605
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
107726718
CY2023Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1313
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1222805
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1527256
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23213504
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18199399
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
302426714
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
251147700
CY2023Q2 us-gaap Assets
Assets
368958912
CY2022Q4 us-gaap Assets
Assets
322882733
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12105250
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10701281
CY2023Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
6073
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22380
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6398115
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7462290
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6538485
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16508253
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4026595
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3139289
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6583334
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2250000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
14113477
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7297815
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
49771329
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47381308
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
148861810
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125521520
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22096232
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17314464
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
178031
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
502070
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
171136073
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
143338054
CY2023Q2 us-gaap Liabilities
Liabilities
220907402
CY2022Q4 us-gaap Liabilities
Liabilities
190719362
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
86994
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
86994
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
87
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71730449
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70590451
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
71730
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
56353
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
201116605
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180381641
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51103785
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46241583
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2033127
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2033127
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
148051510
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
368958912
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
322882733
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42375100
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44263392
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
82376036
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76040946
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
17856050
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
19106944
us-gaap Cost Of Revenue
CostOfRevenue
34824320
us-gaap Cost Of Revenue
CostOfRevenue
39946995
CY2023Q2 us-gaap Gross Profit
GrossProfit
24519050
CY2022Q2 us-gaap Gross Profit
GrossProfit
25156448
us-gaap Gross Profit
GrossProfit
47551716
us-gaap Gross Profit
GrossProfit
36093951
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8838936
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6666044
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19054847
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13521755
CY2023Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
487860
CY2022Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1516544
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1675224
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
4101016
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7389172
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7240368
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13154165
us-gaap Labor And Related Expense
LaborAndRelatedExpense
12537145
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2845691
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
697842
us-gaap Share Based Compensation
ShareBasedCompensation
3060235
us-gaap Share Based Compensation
ShareBasedCompensation
1688925
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
19561659
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
16120798
us-gaap Operating Expenses
OperatingExpenses
36944471
us-gaap Operating Expenses
OperatingExpenses
31848841
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4957391
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9035650
us-gaap Operating Income Loss
OperatingIncomeLoss
10607245
us-gaap Operating Income Loss
OperatingIncomeLoss
4245110
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7890439
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7489205
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15636294
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14791459
CY2023Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1468083
CY2022Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
36705764
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
9969768
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
23288292
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-5264
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1816
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-13813
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6422356
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29211295
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5664710
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8483027
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1464965
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-352884
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38246945
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4942535
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12728137
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5142559
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4405962
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9804737
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5665856
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6607524
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33840983
us-gaap Net Income Loss
NetIncomeLoss
-4862202
us-gaap Net Income Loss
NetIncomeLoss
7062281
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2353883
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1766575
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4383277
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3510019
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8961407
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32074408
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9245479
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3552262
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60538317
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49178494
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57999461
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49178494
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60538317
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133481667
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57999461
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133481667
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6607524
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33840983
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4862202
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7062281
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
133569665
us-gaap Net Income Loss
NetIncomeLoss
7062281
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15100000
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
385006
shwz Return Of Common Stock As Compensation To Employee Officers And Or Directors
ReturnOfCommonStockAsCompensationToEmployeeOfficersAndOrDirectors
-473642
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1688925
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
157332235
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132163371
us-gaap Net Income Loss
NetIncomeLoss
-4862202
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
17292990
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
397116
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3060235
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
148051510
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
120982046
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33840983
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1900000
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
385006
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
224200
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
157332235
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
134123345
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6607524
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
17292990
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
397116
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2845691
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
148051510
us-gaap Net Income Loss
NetIncomeLoss
-4862202
us-gaap Net Income Loss
NetIncomeLoss
7062281
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10826289
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1553817
shwz Non Cash Interest Expenses
NonCashInterestExpenses
1992280
shwz Non Cash Interest Expenses
NonCashInterestExpenses
2165366
shwz Noncash Lease Expense
NoncashLeaseExpense
3316171
shwz Noncash Lease Expense
NoncashLeaseExpense
4705059
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
324039
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
9969768
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
23288292
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
843025
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
843025
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4088319
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3590017
us-gaap Gain Loss On Investments
GainLossOnInvestments
1816
us-gaap Gain Loss On Investments
GainLossOnInvestments
-13813
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3060235
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
776917
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
923614
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1689914
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5937100
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3924172
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
909663
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5219898
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-304451
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
185589
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2661202
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8873051
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-3853458
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
5922458
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6815662
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1163770
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1803570
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9863589
us-gaap Proceeds From Collection Of Finance Receivables
ProceedsFromCollectionOfFinanceReceivables
10631
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
15834378
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
56875923
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4704093
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7076116
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2825
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20527840
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63954864
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
750000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
397116
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1280660
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1280660
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19077154
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-72537793
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38949253
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106400216
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19872099
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33862423
us-gaap Interest Paid Net
InterestPaidNet
10931090
us-gaap Interest Paid Net
InterestPaidNet
9004575
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3500000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6840000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
4462594
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
10172788
shwz Issuance Of Stock As Payments For Acquisitions
IssuanceOfStockAsPaymentsForAcquisitions
17277998
shwz Issuance Of Stock As Payments For Acquisitions
IssuanceOfStockAsPaymentsForAcquisitions
15100450
shwz Issuance Of Debt For Acquisition
IssuanceOfDebtForAcquisition
21500000
shwz Issuance Of Debt For Acquisition
IssuanceOfDebtForAcquisition
17000000
shwz Noncash Or Part Noncash Acquisition Tangible And Intangible Assets Acquired Net Of Cash
NoncashOrPartNoncashAcquisitionTangibleAndIntangibleAssetsAcquiredNetOfCash
47090774
shwz Noncash Or Part Noncash Acquisition Tangible And Intangible Assets Acquired Net Of Cash
NoncashOrPartNoncashAcquisitionTangibleAndIntangibleAssetsAcquiredNetOfCash
30107975
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
3535029
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1837221
shwz Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
13592071
shwz Noncash Or Part Noncash Acquisition Goodwill Acquired
NoncashOrPartNoncashAcquisitionGoodwillAcquired
60705169
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2310920
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2325482
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
13194868
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
14504490
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18315494
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5724210
CY2023Q2 us-gaap Inventory Net
InventoryNet
33821282
CY2022Q4 us-gaap Inventory Net
InventoryNet
22554182
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38136246
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
31989003
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7007889
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4899977
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31128357
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27089026
CY2023Q2 us-gaap Depreciation
Depreciation
1127374
us-gaap Depreciation
Depreciation
2107912
CY2022Q2 us-gaap Depreciation
Depreciation
821757
us-gaap Depreciation
Depreciation
1223706
CY2023Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
45489903
CY2023Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-6783246
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
91528065
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4561301
CY2022Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
51018372
CY2022Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
35544920
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
85537479
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
8257652
CY2022 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
181818767
CY2022 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-16920270
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
13592071
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-32229242
CY2023Q2 us-gaap Goodwill
Goodwill
75968130
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
11719306
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Goodwill
Goodwill
43316267
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
62368339
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
640001
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
11719306
CY2022Q4 us-gaap Goodwill
Goodwill
94605301
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
193874422
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24981817
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
124017580
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16290862
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3520096
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8690955
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2138846
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4277693
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7426504
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
14511759
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14206620
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13330843
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12794764
CY2023Q2 shwz Finite Lived Intangible Asset Amortization Expense After Year Four
FiniteLivedIntangibleAssetAmortizationExpenseAfterYearFour
106622115
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
168892605
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
34923013
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-18414760
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
16508253
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-8501685
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
8006568
CY2023Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1468083
CY2023Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
6538485
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5760669
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6603695
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
36904857
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
40993176
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
155445144
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
127771520
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6583334
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2250000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
148861810
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125521520
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
5500000
CY2023Q2 shwz Long Term Debt Unamortized Debt Issuance Costs Remainder Of Fiscal Year
LongTermDebtUnamortizedDebtIssuanceCostsRemainderOfFiscalYear
843023
CY2023Q2 shwz Long Term Debt Unamortized Debt Discount Remainder Of Fiscal Year
LongTermDebtUnamortizedDebtDiscountRemainderOfFiscalYear
4435174
CY2023Q2 shwz Total Long Term Debt Remainder Of Fiscal Year
TotalLongTermDebtRemainderOfFiscalYear
221803
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5500000
CY2023Q2 shwz Long Term Debt Unamortized Debt Issuance Costs Year One
LongTermDebtUnamortizedDebtIssuanceCostsYearOne
1686049
CY2023Q2 shwz Long Term Debt Unamortized Debt Discount Year One
LongTermDebtUnamortizedDebtDiscountYearOne
9734935
CY2023Q2 shwz Total Long Term Debt Year One
TotalLongTermDebtYearOne
-5920984
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
27624655
CY2023Q2 shwz Long Term Debt Unamortized Debt Issuance Costs Year Two
LongTermDebtUnamortizedDebtIssuanceCostsYearTwo
1686049
CY2023Q2 shwz Long Term Debt Unamortized Debt Discount Year Two
LongTermDebtUnamortizedDebtDiscountYearTwo
11057799
CY2023Q2 shwz Total Long Term Debt Year Two
TotalLongTermDebtYearTwo
14880807
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
146583106
CY2023Q2 shwz Long Term Debt Unamortized Debt Issuance Costs Year Three
LongTermDebtUnamortizedDebtIssuanceCostsYearThree
1545548
CY2023Q2 shwz Long Term Debt Unamortized Debt Discount Year Three
LongTermDebtUnamortizedDebtDiscountYearThree
11676949
CY2023Q2 shwz Total Long Term Debt Year Three
TotalLongTermDebtYearThree
133360609
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
12902909
CY2023Q2 shwz Total Long Term Debt Year Four
TotalLongTermDebtYearFour
12902909
CY2023Q2 shwz Long Term Debt Maturities Repayments Of Principal
LongTermDebtMaturitiesRepaymentsOfPrincipal
198110670
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5760669
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
36904857
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
155445144
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23213504
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4026595
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22096232
CY2023Q2 shwz Lessee Operating Lease Liability Payments Due Next Twelve Months1
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths1
39361669
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13178774
CY2023Q2 shwz Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
26182895
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3593197
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6336199
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5435299
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5070471
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3902717
CY2023Q2 shwz Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
15023786
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
39361669
shwz Number Of Classes Of Stock
NumberOfClassesOfStock
2
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
86994
CY2023Q2 shwz Escrow Shares
EscrowShares
944
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08
us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
1000
CY2023Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
1.20
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2353883
us-gaap Dividends Preferred Stock
DividendsPreferredStock
4383277
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1766575
us-gaap Dividends Preferred Stock
DividendsPreferredStock
3510019
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71730449
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70590451
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
219848
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56352545
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55212547
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
920150
CY2022 shwz Common Stock Held In Escrow
CommonStockHeldInEscrow
219848
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2845691
us-gaap Share Based Compensation
ShareBasedCompensation
3060235
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
697842
us-gaap Share Based Compensation
ShareBasedCompensation
1688925
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10356500
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.13
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y29D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
772996
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3340000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.20
shwz Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y11M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
495000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.80
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
462500
shwz Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
1.94
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12739000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M1D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
326485
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
12739000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y5M1D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
326485
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6607524
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
33840983
us-gaap Net Income Loss
NetIncomeLoss
-4862202
us-gaap Net Income Loss
NetIncomeLoss
7062281
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2353883
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1766575
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4383277
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3510019
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8961407
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32074408
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9245479
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3552262
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60538317
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49178494
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57999461
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49178494
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8961407
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32074408
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9245479
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3552262
CY2023Q2 shwz Add Investor Note Accrued Interest
AddInvestorNoteAccruedInterest
421512
shwz Add Investor Note Accrued Interest
AddInvestorNoteAccruedInterest
843026
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2088386
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4088319
CY2023Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1468083
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-9969768
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7919592
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
32074408
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14283902
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3552262
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60538317
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49178494
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57999461
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49178494
CY2023Q2 shwz Dilutive Effect Of Investor Notes
DilutiveEffectOfInvestorNotes
45772777
shwz Dilutive Effect Of Investor Notes
DilutiveEffectOfInvestorNotes
47340185
CY2022Q2 shwz Dilutive Effect Of Warrants
DilutiveEffectOfWarrants
1483994
shwz Dilutive Effect Of Warrants
DilutiveEffectOfWarrants
1483994
CY2022Q2 shwz Dilutive Effect Of Options
DilutiveEffectOfOptions
1114415
shwz Dilutive Effect Of Options
DilutiveEffectOfOptions
1114415
CY2022Q2 shwz Dilutive Effect Of Preferred Stock
DilutiveEffectOfPreferredStock
81704765
shwz Dilutive Effect Of Preferred Stock
DilutiveEffectOfPreferredStock
81704765
CY2023Q2 shwz Weighted Average Number Of Diluted Shares Outstanding Excluding Common Share Equivalents
WeightedAverageNumberOfDilutedSharesOutstandingExcludingCommonShareEquivalents
106311094
CY2022Q2 shwz Weighted Average Number Of Diluted Shares Outstanding Excluding Common Share Equivalents
WeightedAverageNumberOfDilutedSharesOutstandingExcludingCommonShareEquivalents
133481667
shwz Weighted Average Number Of Diluted Shares Outstanding Excluding Common Share Equivalents
WeightedAverageNumberOfDilutedSharesOutstandingExcludingCommonShareEquivalents
105339646
shwz Weighted Average Number Of Diluted Shares Outstanding Excluding Common Share Equivalents
WeightedAverageNumberOfDilutedSharesOutstandingExcludingCommonShareEquivalents
133481667
CY2023Q2 shwz Diluted Earnings Per Share Excluding Common Share Equivalents
DilutedEarningsPerShareExcludingCommonShareEquivalents
-0.07
CY2022Q2 shwz Diluted Earnings Per Share Excluding Common Share Equivalents
DilutedEarningsPerShareExcludingCommonShareEquivalents
0.24
shwz Diluted Earnings Per Share Excluding Common Share Equivalents
DilutedEarningsPerShareExcludingCommonShareEquivalents
-0.14
shwz Diluted Earnings Per Share Excluding Common Share Equivalents
DilutedEarningsPerShareExcludingCommonShareEquivalents
0.03
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1464965
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38246945
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5142559
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4405962
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-3.5104
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1152
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4942535
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12728137
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9804737
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5665856
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.98
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.4451
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3

Files In Submission

Name View Source Status
0001558370-23-014456-index-headers.html Edgar Link pending
0001558370-23-014456-index.html Edgar Link pending
0001558370-23-014456.txt Edgar Link pending
0001558370-23-014456-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
shwz-20230630.xsd Edgar Link pending
shwz-20230630x10q.htm Edgar Link pending
shwz-20230630xex10d3.htm Edgar Link pending
shwz-20230630xex10d4.htm Edgar Link pending
shwz-20230630xex31d1.htm Edgar Link pending
shwz-20230630xex31d2.htm Edgar Link pending
shwz-20230630xex32.htm Edgar Link pending
shwz-20230630_def.xml Edgar Link unprocessable
shwz-20230630_lab.xml Edgar Link unprocessable
shwz-20230630_pre.xml Edgar Link unprocessable
shwz-20230630x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
shwz-20230630_cal.xml Edgar Link unprocessable